ODQ

CAS No. 41443-28-1

ODQ( —— )

Catalog No. M24377 CAS No. 41443-28-1

ODQ is an effective and selective soluble guanylyl cyclase (sGC) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 62 In Stock
2MG 40 In Stock
5MG 65 In Stock
10MG 96 In Stock
25MG 145 In Stock
50MG 215 In Stock
100MG 322 In Stock
200MG 483 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ODQ
  • Note
    Research use only, not for human use.
  • Brief Description
    ODQ is an effective and selective soluble guanylyl cyclase (sGC) inhibitor.
  • Description
    ODQ is an effective and selective soluble guanylyl cyclase (sGC) inhibitor.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Anesthetized, male Wistar rats Dosage:2 mg/kg Administration:I.p.Result:Attenuated the renal dysfunction, lung injury, and hepatocellular injury caused by lipoteichoic acid/peptidoglycan or lipopolysaccharide.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    sGC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41443-28-1
  • Formula Weight
    187.15
  • Molecular Formula
    C9H5N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (534.33 mM; Need ultrasonic)
  • SMILES
    O=C1ON=C2N1C3=C(C=CC=C3)N=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol. 1995 Aug;48(2):184-8. PubMed PMID: 7544433.
molnova catalog
related products
  • Cyclo(Phe-Pro)

    Cyclo(Phe-Pro) known as a secondary metabolite of some bacteria and fungi, is also produced by Vibrio vulnificus.

  • Halleridone

    halleridone activated Nrf2-mediated HO-1 expression and inhibited Aβ1-42-overexpressed microglial BV-2 cell activation.

  • GLP-2 (1-34) (human)

    GLP-2 (1-34) (human) is a polypeptide released from the intestine within minutes after food intake. GLP-2 (1-34) (human) can be used for the research of bone remodeling processes.